NDC Code(s) : 51079-374-01, 51079-374-20, 51079-375-01, 51079-375-20, 51079-141-01, 51079-141-20
Packager : Mylan Institutional Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : CIV
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
| Chlordiazepoxide HydrochlorideChlordiazepoxide Hydrochloride CAPSULE | ||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
| Chlordiazepoxide HydrochlorideChlordiazepoxide Hydrochloride CAPSULE | ||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||
| Chlordiazepoxide HydrochlorideChlordiazepoxide Hydrochloride CAPSULE | ||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
| LABELER - Mylan Institutional Inc.(039615992) |
PRINCIPAL DISPLAY PANEL
NDC 51079-374-20
Chlordiazepoxide
Hydrochloride Capsules, USP
5 mg
C-IV
100 Capsules (10 x 10)
Each capsule contains 5 mg
chlordiazepoxide hydrochloride, USP.
Usual Dosage:See accompanying
prescribing information and
Medication Guide.
Store at 20° to 25°C (68° to 77°F). [See USP
Controlled Room Temperature] in a dry place.
Protect from light.
Manufactured for:
Teva Pharmaceuticals USA, Inc.
North Wales, PA 19454
Rx only
S-12851
Distributed by:
Mylan Institutional Inc.
Rockford, IL 61103 U.S.A.
This unit dose package is not child resistant.
For institutional use only.
Keep this and all drugs out of the reach of children.
This container provides light-resistance.
See window for lot number and expiration date.
PRINCIPAL DISPLAY PANEL
NDC 51079-375-20
Chlordiazepoxide
Hydrochloride Capsules, USP
10 mg
C-IV
100 Capsules (10 x 10)
Each capsule contains 10 mg
chlordiazepoxide hydrochloride, USP.
Usual Dosage:See accompanying
prescribing information and
Medication Guide.
Store at 20° to 25°C (68° to 77°F). [See USP
Controlled Room Temperature] in a dry place.
Protect from light.
Manufactured for:
Teva Pharmaceuticals USA, Inc.
North Wales, PA 19454
Rx only
S-12852
Distributed by:
Mylan Institutional Inc.
Rockford, IL 61103 U.S.A.
This unit dose package is not child resistant.
For institutional use only.
Keep this and all drugs out of the reach of children.
This container provides light-resistance.
See window for lot number and expiration date.
PRINCIPAL DISPLAY PANEL
NDC 51079-141-20
Chlordiazepoxide
Hydrochloride Capsules, USP
25 mg
C-IV
100 Capsules (10 x 10)
Each capsule contains 25 mg
chlordiazepoxide hydrochloride, USP.
Usual Dosage:See accompanying
prescribing information and
Medication Guide.
Store at 20° to 25°C (68° to 77°F). [See USP
Controlled Room Temperature] in a dry place.
Protect from light.
Manufactured for:
Teva Pharmaceuticals USA, Inc.
North Wales, PA 19454
Rx only
S-12853
Distributed by:
Mylan Institutional Inc.
Rockford, IL 61103 U.S.A.
This unit dose package is not child resistant.
For institutional use only.
Keep this and all drugs out of the reach of children.
This container provides light-resistance.
See window for lot number and expiration date.
